Human HER2+ Breast Cancer Susceptibility to Poly(ADP-Ribose) Polymerase Inhibitors Independent of a Homologous Recombination Repair Defect von Yang, E.S, Nowsheen, S, Cooper, T, Bonner, J.A, LoBuglio, A.F

Volltext

Synthetic Lethal Interactions Between EGFR and PARP Inhibition in Triple Negative Breast Cancer von Nowsheen, S, Cooper, T, LoBuglio, A.F, Bonner, J.A, Yang, E.S

Volltext

Biodistribution and Clearance of In-111/Y-90-IDEC-159 in Patients with Metastatic Colorectal Adenocarcinoma von Shen, S, Forero, A, Meredith, R.F, LoBuglio, A.F

Volltext

Clearing of cells bearing the bcl-2 [t(14;18)] translocation from blood and marrow of patients treated with rituximab alone or in combination with CHOP chemotherapy von Czuczman, M. S., Grillo-López, A. J., McLaughlin, P., White, C. A., Saleh, M., Gordon, L., LoBuglio, A. F., Rosenberg, J., Alkuzweny, B., Maloney, D.

Volltext

Impact of Full Dose of Rituximab on Pharmacokinetics and Dosimetry of Zevalin for Patients with Non-Hodgkin’s Lymphoma von Shen, S., Forero, A., Meredith, R.F., LoBuglio, A.F.

Volltext

Targeted radiotherapy potentiates the cytotoxicity of a novel anti-human DR5 monoclonal antibody in prostate cancer von Zhou, T, Oliver, P.G, LoBuglio, A.F, Arafat, W.O

Volltext

EFFICACY OF ANTI-DEATH RECEPTOR 5 (DR5) ANTIBODY (TRA-8) AGAINST PRIMARY HUMAN OVARIAN CARCINOMA USING A NOVEL EX VIVO TISSUE SLICE MODEL von Estes, J.M., Oliver, P.G., Zhou, T., Wang, W., Grizzle, W.E., Alvarez, R.D., Straughn, J.M., LoBuglio, A.F., Buchsbaum, D.J.

Volltext

Improved Prediction of Myelotoxicity Using a Patient-Specific Imaging Dose Estimate for Non-Marrow-Targeting 90Y-Antibody Therapy von Shen, Sui, Meredith, Ruby F, Duan, Jun, Macey, Daniel J, Khazaeli, M.B, Robert, Francisco, LoBuglio, Albert F

Volltext

Phase I study of anti-epidermal growth factor receptor (anti-EGFR) antibody C225 in combination with irradiation in patients with advanced squamous cell carcinoma of the head and n... von Ezekiel, M.P., Robert, F., Meredith, R.F., Spencer, S.A., Newsome, J., Khazaeli, M.B., Peters, G.E., Saleh, M., LoBuglio, A.F., Waksal, H.W.

Volltext

503 Phase I radioimmunotherapy (RIT) study of 90Y-CC49 monoclonal antibody (MAb) therapy in patients with advanced non-small cell lung cancer (NSCLC) von Robert, F., Meredith, R.F., Khazaeli, M.B., Russell, C., Grizzle, W., Newsome, J., Saleh, M., LoBuglio, A.F.

Volltext

Radioimmunoassay of free β-subunit of human chorionic gonadotropin as a prognostic test for persistent trophoblastic disease in molar pregnancy von Khazaeli, M.B., Hedayat, M.M., Hatch, K.D., To, A.C.W., Soong, S.-j., Shingleton, H.M., Boots, L.R., LoBuglio, A.F.

Volltext

Quantitative assay of a human monoclonal IgM antibody (HA-1A) in human serum von Khazaeli, M.B., Rogers, K.J., LoBuglio, A.F.

Volltext

In-111 labeled monoclonal anti-carcinoembryonic antigen antibody (ZCE025) in the immunoscintigraphic imaging of metastatic antigen-producing adenocarcinomas von Saleh, M N, Wheeler, R H, Lee, J Y, Khazaeli, M B, Unger, M W, Russell, C H, LoBuglio, A F

Volltext

Identification of hypoxanthine as the major component of a chromatographic fraction of transfer factor von O'Dorisio, M.S., Neidhart, J.A., Daniel, F.B., Balcerzak, S.P., LoBuglio, A.F.

Volltext